FOLFOX + Immunotherapy With Intrahepatic Oxaliplatin for Patients With Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- N/A
Patients' Guidance With Onco-Coaching and CANKADO on Systemic Chemotherapy for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- N/A
A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and Safety
- Status
- UNKNOWN
- Phase
- PHASE3
Early Detection of Relapses in Stage IV Colorectal Cancer Patients
- Status
- UNKNOWN
- Phase
- N/A
The Gene Profiles of Primary and Heterogeneous Metastases of Colorectal Cancer
- Status
- UNKNOWN
- Phase
- N/A
Re-challenge of Anti-EGFR for Patients With RAS/BRAF Wild-type Metastatic CRC
- Status
- COMPLETED
- Phase
- PHASE2
Sintilimab (IBI308) Combined With Bevacizumab + XELOX Regimen in Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Randomized Phase III Study Comparing Maintenance Treatment With Fluoropyrimidine + Bevacizumab Versus Fluoropyrimidine After Induction Chemotherapy for a Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC)
- Status
- TERMINATED
- Phase
- PHASE2
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Modelle 001, TS-inhibition in Colorectal Liver Metastases Comparing Arfolitixorin and Calciumfolinate
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Rivoceranib and Trifluridine/Tipiracil for Metastatic Colorectal Cancer (mCRC)
- Status
- TERMINATED
- Phase
- PHASE1